Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Closing out this discussion of post-ASH 2022 perspectives, Matthew Lunning, DO, FACP, shares important clinical practice pearls for physicians considering CAR T-cell therapy for patients with LBCL.

Related Videos
Jeffery Zonder, MD
Jeffery Zonder, MD
Abhinav Deol, MD
Veronika Bachanova, MD, PhD
Eunice Wang, MD
Craig Sauter, MD
Matthew Frank, MD, PhD
Related Content